Paul Dunn
Has grant
Assistant Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
About
Paul Dunn is an Assistant Professor at Bond University, Australia. His research primarily focuses on genetic testing, particularly in the context of preimplantation genetic testing, microbiome profiling, and small vessel disease. Recent publications highlight his work on sequencing technologies and their application in diagnosing various conditions, including Alzheimer’s disease and CADASIL.
Recent Grants
Grant: Close
Identifying New Genes and Genetic Factors Causing CADASIL and related Stroke and Vascular Dementia Disorders
Open Date: 2019-01-01
Close Date: 2021-12-01
Articles (15)
Year:
2026
Year:
2026
Year:
2026
The continued development of assisted reproductive technologies has aimed to improve pregnancy outcomes through screening methods for the identification of embryos with monogenic disorders, chromosomal aneuploidy or structural abnormalities. There is an increased risk of chromosomal abnormalities for patients with advanced maternal age, recurrent implantation failure and recurrent pregnancy loss. To address this, preimplantation genetic testing for aneuploidy has evolved through several methods since the 1990s, when it first began through fluorescence in situ hybridisation. The limitations of these early methods were overcome with the progression in technology that enabled the screening of all 23 chromosome pairs. These methods included microarray methods and next-generation sequencing platforms. Currently, these are used for PGT-A; however, for IVF clinics to carry out PGT-A utilising these methods, samples are sent to external laboratories capable of carrying out these methods. More recently, nanopore sequencing has emerged, which may overcome these limitations and be carried out within IVF clinics to facilitate faster patient results. This review focuses on the evolution of PGT-A methods through next-generation sequencing and the current status of these methods.
Year:
2025
Background The female genital tract microbiome has become a particular area of interest in improving assisted reproductive technology (ART) outcomes with the emergence of next-generation sequencing (NGS) technology. However, NGS assessment of microbiomes currently lacks uniformity and poses significant challenges for accurate and precise bacterial population representation. Objective As multiple NGS platforms and assays have been developed in recent years for microbiome investigation—including the advent of long-read sequencing technologies—this work aimed to identify current trends and practices undertaken in female genital tract microbiome investigations. Results Areas like sample collection and transport, DNA extraction, 16S amplification vs. metagenomics, NGS library preparation, and bioinformatic analysis demonstrated a detrimental lack of uniformity. The lack of uniformity present is a significant limitation characterised by gap discrepancies in generation and interpretation of results. Minimal consistency was observed in primer design, DNA extraction techniques, sample transport, and bioinformatic analyses. Conclusion With third-generation sequencing technology highlighted as a promising tool in microbiota-based research via full-length 16S rRNA sequencing, there is a desperate need for future studies to investigate and optimise methodological approaches of the genital tract microbiome to ensure better uniformity of methods and results interpretation to improve clinical impact. Graphical Abstract
Year:
2025
Purpose Rising demand for assisted reproductive technologies (ART) with limited improvements in success rates has driven interest in the impact of the vaginal microbiome on fertility outcomes. In order to fully examine the relationship between the vaginal microbiome and fertility outcomes, methodologies and technological developments must be standardised and benchmarked to provide the most accurate assessment of microbial population representation. Methods This study sought to investigate the utility of 16S sequencing and bioinformatic approaches using nanopore sequencing to characterize core vaginal microbiota in a healthy Australian cohort of reproductive-age women. Results Optimisation and comparison of different PCR strategies for whole 16S amplification was undertaken, along with the generation of bioinformatic analysis strategies. Initial qPCR identified the 27F-YM (MIX) primer as the most sensitive for C. trachomatis . However, nanopore sequencing revealed no detectable C. trachomatis across all six samples. Among the bioinformatic tools, Porechop with NanoCLUST most accurately identified microbial presence. Community state type (CST) I—characterised by Lactobacillus crispatus dominance—was identified as the most common CST (66%), aligning with patterns of a healthy vaginal microbiome. Conclusion The findings highlight a Lactobacillus -rich microbiome as the most common among healthy females; however, further refinement—potentially through a metagenomics approach—is recommended to address 16S rRNA primer limitations to enable improved accuracy of microbial detection for the vaginal microbiome. Graphical Abstract
Year:
2025
Year:
2025
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2021
Year:
2020
Year:
2020
Year:
2020
Collaborators (10)
Luke Haseler
Curtin University
Lyn R. Griffiths
Queensland University of Technology
Xu Yan
Associate Professor
Victoria University
Hayley O'Neill
Bond University
Catherine McDermott
Bond University
Kristen MacKenzie-Shalders
Assistant Professor
Bond University
Kevin Ashton
Associate Professor
Bond University
Nicholas Harvey
Bond University
Larisa Haupt
Queensland University of Technology
Heidi Sutherland
Queensland University of Technology
Make your next move.
Prepare your application
Review drafts before you send them.